Brunton, Holly ;
Caligiuri, Giuseppina ;
Cunningham, Richard...
Brunton , H , Caligiuri , G , Cunningham , R , Upstill-Goddard , R , Bailey , U-M , Garner , I M , Nourse , C , Dreyer , S , Jones , M , Moran-Jones , K , Wright , D W , Paulus-Hock , V , Nixon , C , Thomson , G , Jamieson , N B , McGregor , G A , Evers , L , McKay , C J , Gulati , A , Brough , R , Bajrami , I , Pettitt , S J , Dziubinski , M L , Barry , S T , Grützmann , R , Brown , R , Curry , E , Pajic , M , Musgrove , E A , Petersen , G M , Shanks , E , Ashworth , A , Crawford , H C , Simeone , D M , Froeling , F E M , Lord , C J , Mukhopadhyay , D , Pilarsky , C , Grimmond , S E , Morton , J P , Sansom , O J & Chang , D K & Bailey , P J & Biankin , A V 2020 , ' HNF4A and GATA6 loss reveals therapeutically actionable subtypes in pancreatic cancer ' , Cell Reports , vol. 31 , no. 6 , 107625 , pp. 1-17 . https://doi.org/10.1016/j.celrep.2020.107625.
,
2020
